Autoantibody profiling in APS

Lupus

Volumn 23, Issue 12, 2014, Pages 1262-1264

  Roggenbuck, D ^a,b   Somma, V ^a   Schierack, P ^b   Borghi, M O ^c,d   Meroni, P L ^c,d  

^a Medipan GmbH   (Germany)

^b BRANDENBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

antiphospholipid antibody; Antiphospholipid syndrome; line immunoassay

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; HIGH MOLECULAR WEIGHT KININOGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN; BETA2 GLYCOPROTEIN 1;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CARDIOVASCULAR RISK; CONFERENCE PAPER; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; LINE IMMUNOASSAY; PERIPHERAL NEUROPATHY; SPONTANEOUS ABORTION; TREPONEMATOSIS; VEIN THROMBOSIS; BLOOD; IMMUNOLOGY;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS;

EID: 84908672916     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314534305     Document Type: Conference Paper

References (11)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
2. Nalli C, Andreoli L, Casu C, et al. Management of recurrent thrombosis in antiphospholipid syndrome. Curr Rheumatol Rep. 2014 ; 16: 405-405
3. Meroni PL, Borghi MO, Raschi E, et al. Pathogenesis of antiphospholipid syndrome: Understanding the antibodies. Nat Rev Rheumatol. 2011 ; 7: 330-339
4. Otomo K, Atsumi T, Amengual O, et al. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum. 2012 ; 64: 504-512
5. Andreoli L, Tincani A. Beyond the 'Syndrome': Antiphospholipid antibodies as risk factors. Arthritis Rheum. 2012 ; 64: 342-345
6. Pengo V, Banzato A, Denas G, et al. Correct laboratory approach to APS diagnosis and monitoring. Autoimmun Rev. 2013 ; 12: 832-834
7. Roggenbuck D, Egerer K, von Landenberg P, et al. Antiphospholipid antibody profiling - Time for a new technical approach. Autoimmun Rev. 2012 ; 11: 821-826
8. Roggenbuck D, Egerer K, Feist E, et al. Antiphospholipid antibody profiling: Association with the clinical phenotype of antiphospholipid syndrome? Comment on the article by Otomo et al. Arthritis Rheum. 2012 ; 64: 2807-2808
9. Conrad K, Schneider H, Ziemssen T, et al. A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies. Ann N Y Acad Sci. 2007 ; 1109: 256-264
10. Agostinis C, Durigutto P, Sblattero D, et al. A non complement-fixing antibody to β2 glycoprotein I as a novel therapy to control abortions and thrombosis in antiphospholipid syndrome. Blood 2014; in press. DOI:10.1182/blood-2013-11-537704.
11. Egerer K, Roggenbuck D, Buettner T, et al. Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay. Arthritis Res Ther. 2011 ; 13: R118 - R118